FFMMX | SVALX | FFMMX / SVALX | |
Total Expense Ratio | 0.36 | 0.79 | 46% |
Annual Report Gross Expense Ratio | 0.36 | 0.85 | 42% |
Fund Existence | 5 years | 9 years | - |
Gain YTD | 14.169 | 11.890 | 119% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111B | 8.67B | 1,280% |
Annual Yield % from dividends | 1.69 | 3.22 | 52% |
Returns for 1 year | 5.58 | 4.96 | 112% |
Returns for 3 years | 41.22 | 29.86 | 138% |
Returns for 5 years | N/A | 66.46 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 73.75 | 0.46 | +0.63% |
Janus Henderson Global Life Sciences A | |||
GMVCX | 15.68 | 0.03 | +0.19% |
Goldman Sachs Small/Mid Cap Equity C | |||
VDIPX | 30.50 | 0.03 | +0.10% |
Vanguard Developed Markets Index Ins Pls | |||
SCOBX | 46.28 | -0.03 | -0.06% |
DWS International Growth S | |||
TAIWX | 13.94 | -0.09 | -0.64% |
Nuveen Quant Intl Small Cap Eq W |